A recent report published by Infinium Global Research on vascular stent market provides an in-depth analysis of segments and sub-segments in the global as well as regional vascular stent market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional vascular stent market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global vascular stent market. According to the report, the global vascular stent market is projected to grow at a CAGR of 7.5% over the forecast period of 2018-2024.
Vascular stents are devices used for relieving the contraction of the blocked blood vessel. The vascular stent is a promising component in the rapid and effective approach to treating cardiovascular and cerebrovascular diseases. In this treatment, vascular stent along with a balloon is inserted into the lesion areas to support the narrow and blocked vessel areas. It also helps in reducing vessel elastic recoil and remodeling, and preserve the patency of the blood flow.
The rising prevalence of cardiovascular disease drives the growth of the vascular stent market. According to the WHO, more than 17 million people die annually from cardiovascular disease (CVD). Vascular stent plays an important role in the treatment of cardiovascular and cerebrovascular diseases. The occurrence of these diseases is rising very rapidly owing to the changing lifestyle habits and environmental conditions that necessitate the use of vascular stents. A vascular stent is used to maintain the patency of structure vessels during the minimally intensive procedure. In addition, growing adoption of vascular stents in the minimally intensive surgeries is anticipated to boost the demand of vascular stent market. .Furthermore, factors such as the growing aging population, rising healthcare expenditure, and helpful medical reimbursement policies contribute to the growth of the vascular stent market.
Moreover, the introduction of biodegradable materials and the metals & polymers with unique technological properties in the manufacturing of vascular stents are projected to create numerous opportunities in the vascular stent market. Additionally, the growing technological advancements in the healthcare sector and the increasing prevalence of chronic diseases are likely to create a positive impact on the vascular stent market in the upcoming years.
Among the geographies, North America holds the maximum market share in the vascular stent market followed by Europe. The growing prevalence of the chronic disease, high adoption of minimally invasive surgery and the presence of large market players are driving the growth of vascular stent market in the North America region. Furthermore, the developed healthcare infrastructure is expected to contribute to the growth of the vascular stent market in the North America region. In addition, Asia-Pacific is the fastest growing region in the vascular stent market owing to the growing geriatric population, rising healthcare expenditures.
The report on global vascular stent market covers segments such as types, material, and mode of delivery, product, and end user. On the basis of types, the sub-markets include dual therapy stent (DTS), bioresorbable vascular scaffold (BVS), bio-engineered stent, a bare metal stent (BMS), and drug eluting stent (DES). On the basis of material, the sub-markets include metallic stents, polymer, and others. On the basis of mode of delivery, the sub-markets include self-expanding stents and balloon-expandable stents. On the basis of product, the sub-markets include peripheral stents, EVAR stent grafts, and coronary stents. On the basis of the end user, the sub-markets include hospitals, cardiac centers, and ambulatory surgical centers.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016-2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in this region. The Asia-Pacific region offers substantial potential for the market growth owing to rapid growth in markets such as India and China.
The report provides profiles of the companies in the market such as Abbott Laboratories, Biosensors International Group, Ltd., Boston Scientific Corporation, Biotronik SE & Co. KG, Endologix, Inc., MicroPort Orthopedics, Inc., MIV Therapeutics Inc., Medtronic PLC, Cardinal Health, Inc., Other Companies
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of vascular stent market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter